N Lum1, K T Wai2, A M C Thar3, K L Show2, A D Harries4,5, N M A Wann6, S Hone1, H N Oo1. 1. National AIDS Programme, Ministry of Health and Sports, Nay Pyi Taw, Myanmar. 2. Department of Medical Research, Ministry of Health and Sports, Nay Pyi Taw, Myanmar. 3. Expanded Programme on Immunization, Department of Public Health, Ministry of Health and Sports, Nay Pyi Taw, Myanmar. 4. International Union Against Tuberculosis and Lung Disease, Paris, France. 5. London School of Hygiene & Tropical Medicine, London, UK. 6. Department of Medical Services, Ministry of Health and Sports, Nay Pyi Taw, Myanmar.
Abstract
SETTING: People who inject drugs (PWID) enrolled for methadone maintenance therapy (MMT) and never previously tested for human immunodeficiency virus (HIV) in Myitkyina Drug Dependency Treatment Hospital, Myitkyina, Kachin State, Myanmar. OBJECTIVES: To compare before (2016) and after (2018) adoption of 'Test and Treat' guidelines for antiretroviral therapy (ART): 1) the demographic profile of PWID, 2) HIV testing uptake and ART initiation in those diagnosed HIV-positive, and 3) time taken for events. DESIGN: This was a cohort study using secondary programme data. RESULTS: In 2016 and 2018, there were respectively 141 and 146 PWID: all were male except for one female and age distribution between the 2 years was similar. In 2018, significantly more PWID were HIV-tested than in 2016 (85% vs. 45%; P ≤ 0.001). Among those tested, the proportions who were HIV-positive were similar (37% in 2016 and 38% in 2018). In 2018, significantly fewer HIV-positive PWID were started on ART than in 2016 (19% vs. 48%; P = 0.01). Median times between enrolment on MMT and HIV testing (2 vs. 1 day) and between being diagnosed HIV-positive and started on ART (31 vs. 17 days) for 2016 and 2018 were not significantly different. CONCLUSION: ART uptake decreased in 2018 compared with 2016, and ways to rectify this are urgently needed.
SETTING: People who inject drugs (PWID) enrolled for methadone maintenance therapy (MMT) and never previously tested for human immunodeficiency virus (HIV) in Myitkyina Drug Dependency Treatment Hospital, Myitkyina, Kachin State, Myanmar. OBJECTIVES: To compare before (2016) and after (2018) adoption of 'Test and Treat' guidelines for antiretroviral therapy (ART): 1) the demographic profile of PWID, 2) HIV testing uptake and ART initiation in those diagnosed HIV-positive, and 3) time taken for events. DESIGN: This was a cohort study using secondary programme data. RESULTS: In 2016 and 2018, there were respectively 141 and 146 PWID: all were male except for one female and age distribution between the 2 years was similar. In 2018, significantly more PWID were HIV-tested than in 2016 (85% vs. 45%; P ≤ 0.001). Among those tested, the proportions who were HIV-positive were similar (37% in 2016 and 38% in 2018). In 2018, significantly fewer HIV-positive PWID were started on ART than in 2016 (19% vs. 48%; P = 0.01). Median times between enrolment on MMT and HIV testing (2 vs. 1 day) and between being diagnosed HIV-positive and started on ART (31 vs. 17 days) for 2016 and 2018 were not significantly different. CONCLUSION: ART uptake decreased in 2018 compared with 2016, and ways to rectify this are urgently needed.
Authors: Bradley M Mathers; Louisa Degenhardt; Benjamin Phillips; Lucas Wiessing; Matthew Hickman; Steffanie A Strathdee; Alex Wodak; Samiran Panda; Mark Tyndall; Abdalla Toufik; Richard P Mattick Journal: Lancet Date: 2008-09-23 Impact factor: 79.321
Authors: Bradley M Mathers; Louisa Degenhardt; Hammad Ali; Lucas Wiessing; Matthew Hickman; Richard P Mattick; Bronwyn Myers; Atul Ambekar; Steffanie A Strathdee Journal: Lancet Date: 2010-02-26 Impact factor: 79.321
Authors: George E Woody; Douglas Bruce; P Todd Korthuis; Sumedha Chhatre; Sabrina Poole; Maureen Hillhouse; Petra Jacobs; James Sorensen; Andrew J Saxon; David Metzger; Walter Ling Journal: J Acquir Immune Defic Syndr Date: 2014-07-01 Impact factor: 3.731
Authors: Olga Tymejczyk; Ellen Brazier; Constantin T Yiannoutsos; Michael Vinikoor; Monique van Lettow; Fred Nalugoda; Mark Urassa; Jean d'Amour Sinayobye; Peter F Rebeiro; Kara Wools-Kaloustian; Mary-Ann Davies; Elizabeth Zaniewski; Nanina Anderegg; Grace Liu; Nathan Ford; Denis Nash Journal: PLoS Med Date: 2019-06-10 Impact factor: 11.069
Authors: Vivian F Go; Rebecca B Hershow; Tetiana Kiriazova; Riza Sarasvita; Quynh Bui; Carl A Latkin; Scott Rose; Erica Hamilton; Kathryn E Lancaster; David Metzger; Irving F Hoffman; William C Miller Journal: AIDS Behav Date: 2019-04
Authors: Bach Xuan Tran; Long Hoang Nguyen; Lan Phuong Nguyen; Cuong Tat Nguyen; Huong Thi Thu Phan; Carl A Latkin Journal: PLoS One Date: 2016-04-05 Impact factor: 3.240